Jago Grahak Jago

May 2024

Covishield side effects: Doctors’ group urges govt to review all Covid vaccines

May 10,2024 New Delhi: In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement (AIM), urged the government to review the science behind all Covid vaccines and audit their commercialisation as well as implementation of active surveillance and monitoring mechanism to ensure vaccine adverse events are identified as early as possible. “The government has wholly ignored the rising number of cases of tragic deaths post-Covid vaccination all the while and continues to promote Covid vaccines as ‘safe and effective’, without scientific investigation and invoking epidemiology,” Dr Tarun Kothari, a radiologist and an activist, said at the press conference. The world is learning about a side effect of the Covid vaccine called Thrombosis with Thrombocytopenia Syndrome (TTS), he said. When the COVID-19 vaccines were being administered, not many people were aware that it was being done without the completion of phase-3 trials. Administration of COVID-19 vaccines was started without the manufacturers having complete information and data on the possible short-term or long-term side effects, or fatalities, said Dr Sujata Mittal, a gynaecologist and oncologist. There is an already low awareness around vaccine injuries, especially in India, she said. Thousands of women reported abnormalities in their menstrual cycles, which was confirmed much later as a side effect of the vaccine in a study published in September 2022, she added. “The Awaken India Movement (AIM) has been collecting details of Covid Vaccine deaths covered by media/social media in India and sharing them with various high authorities of the country since 2021, when the vaccination began. The government has failed to respond to our repeated requests to investigate deaths and debilitation from adverse effects of vaccination,” Dr Kothari said. The AIM urged the government of India to compensate all the victims of Covid vaccines, including their family members, through a mechanism that involves vaccine manufacturers as well. “We also demand establishing fast track courts and vaccine courts to provide swift justice to the vaccine injured and their families,” Dr Mittal said. Besides, active surveillance and monitoring mechanisms should be implemented to ensure vaccine adverse events are identified as early as possible and early treatment protocols must be created and widely publicised so that lives can be saved, she stated. “Review science behind all Covid vaccines and audit their commercialisation,” Dr Kothari said. The United Kingdom-based AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as ‘Covishield’ in partnership with the Serum Institute of India, days after it admitted to rare side effects of blood clotting and lowering of platelet counts. The withdrawal has been initiated due to a surplus of available updated vaccines since the pandemic, the company said in a statement. In India, the company’s partner Serum Institute of India said it has stopped the manufacturing and supply of additional doses of Covishield since December 2021 while reiterating that it had disclosed all rare to very rare side effects, including TTS, in the packaging insert in 2021. AstraZeneca had partnered with Oxford University to develop the COVID-19 vaccine, which was sold as Vaxzevria in Europe. Source: Healthworld

Covishield side effects: Doctors’ group urges govt to review all Covid vaccines Read More »

FLiRT, the new COVID variants are circulating fast: All about symptoms, severity

May 06,2024 New Delhi: COVID is still there among us and recently two new variants have been found in the US. Termed as the “FLiRT” these two variants include KP.2 which overtook the JN.1 subvariant of Omicron in recent weeks. As per the latest data from the U.S. Centers for Disease Control and Prevention, KP.2 is behind one in four infections nationwide. The other FLiRT variant is KP.1.1 which is also circulating in the US but is less widespread than KP.2. It currently accounts for about 7.5 per cent of infections nationwide, per the CDC. Why the name FLiRT? According to the Infectious Disease Society of America, the nickname ‘FLiRT’ is based on the technical names for their mutations. The World Health Organisation (WHO) has reclassified it as a variant of interest and advised close monitoring. The FLiRT variants are spinoffs of JN.1.11.1. They are a part of the Omicron variant. New COVID variant FLiRT symptoms The symptoms of the new variant are similar to those of other Omicron subvariants, such as sore throat, cough, fatigue, nasal congestion, runny nose, headache, muscle aches, fever, and possible loss of taste and smell, experts have said. “The KP.2 variant (also called JN.1.11.1.2) is a descendant of the JN.1 variant and contains several mutations that are associated with escape from vaccine-mediated immune protection. Preliminary research (not yet peer-reviewed) suggests that the estimated relative effective reproduction number of KP.2 (Re) may be 1.22 times higher than the Re for JN.1,” Infectious Disease Society of America has said in a report. FLiRT, which belongs to Omicron’s JN.1 lineage, is rapidly replacing the previous variant, Eris, in the US, the UK, New Zealand, and South Korea, according to Rajeev Gupta, Director of Internal Medicine at the CK Birla Hospital (R), Delhi. “A recent increase in hospitalisation rates in these countries has been attributed to this variant; however, it has remained a relatively small wave. The overall mortality rate has not increased,” he told news agency IANS. “Fortunately, none of the Omicron lineage is able to induce significant lung damage as delta strain did but limited to the upper respiratory tract. The surveillance and vigilance should be kept for major drift in virus,” Dhiren Gupta, a Pediatric Intensivist at Sir Ganga Ram Hospital told IANS and added that these new strains will keep emerging. COVID-19 preventive measures include practicing good hand hygiene by washing hands frequently with soap and water or using hand sanitizer, wearing masks in crowded or indoor settings, maintaining physical distance from others, avoiding large gatherings, and staying home when feeling unwell. Vaccination against COVID-19 is strongly recommended to reduce the risk of infection, severe illness, and transmission. Additionally, following public health guidelines, such as ventilation in indoor spaces and regular testing, can help mitigate the spread of the virus. Combining these measures provides a comprehensive approach to protecting oneself and others from COVID-19. Source: Healthworld

FLiRT, the new COVID variants are circulating fast: All about symptoms, severity Read More »

Covishield deaths could be more than estimates: Parents

May 09,2024 New Delhi: Amid concerns over thrombosis with thrombocytopenia syndrome (TTS) – a serious adverse event that causes blood clots and a low blood platelet count, linked to AstraZeneca’s Covid vaccine – Serum Institute of India (SII), the maker of the product in India, said that it had disclosed all information about the side-effects in its packaging insert in 2021 itself. Safety of vaccines remained “paramount”, a SII spokesperson said on Wednesday. However, a group of parents who lost their children to alleged adverse effects after taking Covishield, believes the number of deaths or serious injury could be much more in India than the government figures even as more parents join in to fight it out in the court. According to reports, AstraZeneca has admitted in a legal document that its Covid vaccine “can, in very rare cases, cause TTS.” “The number of people who have died due to TTS and other causes from vaccine could be much more than the official figures. A lot of people have got in touch with us and will join the fight,” said Venugopalan Govindan, whose 20-year-old daughter, Karunya, died allegedly from complications related to vaccination. Govindan said the AEFI system is inaccessible to common man to even file an adverse report. “The adverse event facility incorporated in COWIN portal after the judgement in Jacob Puliyel case is not functional most of the time, and when it works, it just takes the entry, and we don’t ever hear back about it,” he said. Govindan said that there is no accountability to study and publish causality within a certain timeframe (adverse events suffered in 2015 are decided in 2023). “Data is consciously not made available in an analysable way.” The parents are in touch with lawyers and discussing their case as they contemplate filing a case against its manufacturer, Serum Institute of India (SII). AstraZeneca is facing class action suits in the UK over allegations that the vaccine caused death and serious injury, including thrombosis with thrombocytopenia syndrome (TTS). “Many new families have got in touch and will join in the fight,” Govindan added. A senior member of the Covid working group said that the group finished the assessment related to adverse events in 2022 and the number of people dying due to TTS are “extremely low.” A few of these parents had earlier approached court blaming administration of the Covid vaccine for the death of their children. The petition was mainly against the government and the authorities that cleared the vaccines for administration allegedly without proper studies, and SII was not a party in those cases. After AstraZeneca’s admission surfaced, the parents are now hopeful of justice. “As responsible manufacturers, AstraZeneca and SII should have stopped the manufacturing and supply of these vaccines when 15 European countries either suspended or age-limited these vaccines due to the deaths from blood clots that happened in 2021 March, within a couple of months of the rollout of the vaccine,” he told ET. Source: Pharma

Covishield deaths could be more than estimates: Parents Read More »

Consumer Protection Act| Onus To Prove That Service Was Obtained For Commercial Purpose Is On Service Provider, Not Complainant: SC

May 11,2024 The Supreme Court held that the onus to prove that the service was obtained for a commercial purpose under the Consumer Protection Act, 1986 lies with the service provider and not the consumer. The Bench reiterated that the Consumer Protection Act is a consumer-friendly and beneficial legislation intended to address the grievances of consumers which could not place a negative burden cannot be placed on the consumer to show that the service available was not for a commercial purpose. Justice Pamidighantam Sri Narasimha and Justice Aravind Kumar observed, “Structurally, there are three parts to the definition of a consumer. We can deconstruct Section 2(7)(i) as a matter of illustration. The first part sets out the jurisdictional prerequisites for a person to qualify as a consumer – there must be purchase of goods, for consideration. The second part is an ‘exclusion clause’ [‘carve out’] which has the effect of excluding the person from the definition of a consumer. The carve out applies if the person has obtained goods for the purpose of ‘resale’ or for a ‘commercial purpose’. The third part is an exception to the exclusion clause – it relates to Explanation (a) to Section 2(7) which limits the scope of ‘commercial purpose’. “Since it is always the service provider who pleads that the service was obtained for a commercial purpose, the onus of proving the same would have to be borne by it. Further, it cannot be forgotten that the Consumer Protection Act is a consumer-friendly and beneficial legislation intended to address grievances of consumer”, the court added. Sr. Advocate Shailesh Madiyal represented the appellant, while Sr. Advocate Gopal Sankaranarayanan appeared for the respondent. The Shriram Chits (India) Private Limited Chit Fund) raised a plea arguing that the complainant company was excluded from availing any remedy as it did not come under the definition of a ‘consumer’ under the Act since the service obtained by the complainant was for a commercial purpose. Source: Livelaw

Consumer Protection Act| Onus To Prove That Service Was Obtained For Commercial Purpose Is On Service Provider, Not Complainant: SC Read More »

Issuance Of First Premium Payment Receipt To Insured Would Provide Presumption Of Policy Acceptance By Insurer: Supreme Court

May 11,2024 In a recent decision concerning insurance law, the Supreme Court observed that the issuance of a receipt of the first premium payment by the insurer would provide a presumption of the acceptance of the policy by the insurer. Reversing the findings of the National Consumer Dispute Redressal Commission (“NCDRC”), the bench comprising Justices AS Bopanna and CT Ravikumar, while interpreting the terms and conditions of the insurance contract, noted that the risk of the insured is deemed to be covered from the date of the issuance of the first premium amount receipt by the insurer. In the instance case, the respondent/Life Insurance Corporation (“LIC”) denied the claim of the appellant’s husband/insured on the ground that the policy wouldn’t be deemed to come into force from the date of the issuance of the receipt towards the payment of the first premium amount. However, the appellant contended that the policy would be deemed to be commenced from the date of the receipt of the first premium amount payment made to the LIC. The uncontroversial fact was that the first premium towards the insurance policy was accepted and a duly signed receipt was issued by the LIC on 09.07.1996. The cheque issued by the appellant against the payment of the premium amount was encashed on 12.07.1996. The appellant’s husband died on 14.07.1996 and the policy was prepared on 15.07.1996. Taking reference to the case of D. Srinivas v. SBI Life Insurance Co. Ltd. & Ors, the court framed a question as to whether issuance of receipt towards the first premium payment to the LIC would provide a presumption of the acceptance of the policy by the LIC. Rather than strictly interpreting the terms and conditions of the contract, the Supreme Court in the D. Srinivas case laid down a flexible formula for the court to see whether there was a clear indication of acceptance of the insurance. After noting that the LIC has not disputed the issuance of the First Premium Receipt carrying the assurance, the court while relying upon the dictum of D. Srinivas inclined to hold that there exists a presumption of acceptance of the policy by the LIC since the issuance of First Premium Receipt. Source: Livelaw

Issuance Of First Premium Payment Receipt To Insured Would Provide Presumption Of Policy Acceptance By Insurer: Supreme Court Read More »

Delhi HC asks NBCC to return Rs 76L with interest to homebuyer, awards Rs 5L compensation

May 09,2024 New Delhi: The Delhi High Court has asked NBCC to refund over 76 lakh along with interest to a homebuyer after it failed to deliver possession of his flat, bought it 2012, and also awarded compensation of Rs 5 lakh for causing “extreme mental agony”. Justice Subramonium Prasad, while allowing the homebuyer’s petition against NBCC, observed that purchasing a house is one of the most significant investments an individual or a family makes in their lifetime, and it often involves years of savings, meticulous planning and emotional investment, and therefore compensating wronged homebuyers is not just a matter of rectifying past injustices but also about deterring future misconduct. The petitioner, a retired government employee, said he purchased the flat in ‘NBCC Green View Apartments’, a project launched in 2012 for Gurugram, but in spite of paying the entire sale price of over Rs 76 lakh in 2017, the unit was never handed over to him. In the order passed on May 8, the court observed that the petitioner has been deprived of his money for the last 10 years and “structurally defective houses” have been constructed, leaving him in a complete lurch, and NBCC should be “dealt with severely” for reluctance to pay interest on the amount and ensuring the petitioner’s rehabilitation. Taking judicial notice of geometric progression of price of land in the national capital region, the court said the “pittance” offered by NBCC to only return the principal amount was not an offer in the eyes of law and a rent allowance of Rs.12.50/- per sq. ft. for six months was not an adequate compensation. “This court is, therefore, inclined to allow the instant writ petition directing the respondent/NBCC to return the entire amount of money paid by the Petitioners within a period of six weeks from today along with interest @ 12% from 30.01.2021 till today. In view of the fact that the petitioner has been forced to shift accommodation and fend for himself in the last seven years and has been put to extreme mental agony, this court is inclined to direct the NBCC to pay a sum of Rs. 5 lakh to the petitioner,” the court ordered. “This is a classic case of extreme hardships suffered by a home buyer who has been made to run from pillar to post after having spent his entire life savings… Respondent has been exceedingly unfair in treating the home buyers in this manner,” the court observed. NBCC accused the petitioner of “forum shopping”, stating he has already approached the fora under the RERA Act and the Consumer Protection Act, and therefore the petition should not be entertained by the high court. The court said in the present case, the act of approaching various fora stemmed from “desperation” rather than any strategy. The behaviour, it added, arises out of a sense of frustration, helplessness and lack of legal knowledge. “In the present case, the petitioner entered into the agreement way back in the year 2012. In five years, the petitioner has pumped in over Rs 76 lakh. A ‘No Dues Certificate’ has been given to the petitioner. Structural defects have been found out in the construction after certain persons started occupying the flats. Petitioners and several other persons have been left in lurch and have been forced to knock the doors of various forums,” the court said. “Such a person faces financial crunch to ensure proper education to his children and such a situation he has no other option but to knock on the doors of various forums hoping to get relief and in such a situation the contention of the State that the person is guilty of forum shopping cannot be accepted at all,” it added. The court further said that when builders fail to deliver what was promised, they shatter the trust and financial security of homebuyers and put them in a situation where they may face immense stress, anxiety, uncertainty and ultimately be forced to navigate legal channels for seeking recourse. “The emotional toll of living in limbo, uncertain about the future of their investment and the stability of their living arrangements cannot be understated. Compensating wronged homebuyers is not just a matter of rectifying past injustices but also about deterring future misconduct,” the court observed. Source: Economic TImes

Delhi HC asks NBCC to return Rs 76L with interest to homebuyer, awards Rs 5L compensation Read More »

Consumer rights body asks FSSAI to look into allegations about Nestlé adding sugar to baby products

April 19,2024 The Central Consumer Protection Authority has asked the Food Safety and Standards Authority to investigate claims that baby cereal products sold by Swiss food-processing conglomerate Nestlé in India contain added sugar, PTI reported on Friday. The development comes after an investigation by the Public Eye and the International Baby Food Action Network found that Nestlé was selling products with added sugar to low-income countries. Experts maintain that sugar should not be added to foods fed to babies and young children because it is unnecessary and addictive. However, infant cereals and formulas sold in the European market, including Switzerland, Germany, France and the United Kingdom, did not have any added sugar, the investigation found. Public Eye is a Swiss non-governmental organisation campaigning for fair globalisation and the International Baby Food Action Network is a network of public interest groups working to reduce morbidity and mortality among infants and young children globally. In response to the report, Consumer Affairs Secretary and Central Consumer Protection Authority chief Nidhi Khare told PTI that she had written to the Food Safety and Standards Authority “to take cognisance of the report on Nestlé’s baby product”. The National Commission for Protection of Child Rights has also issued a notice to the Food Safety and Standards Authority about the report. According to the Public Eye and the International Baby Food Action Network report, all 15 Cerelac baby cereal products sold by Nestlé in India contain on average nearly three grams of added sugar per serving. In South Africa too, all Cerelac baby cereals contain four grams or more of added sugar per serving and in Brazil, six out of eight such products sold by Nestlé contain an average of three grams of sugar per serving, they found. On the other hand, infant cereals and formulas sold in the European market did not contain added sugar. In a statement shared with a Nestlé India spokesperson said that the company’s “products manufactured in India are in full and strict compliance with CODEX standards [a commission established by the World Heath Organization and the Food and Agriculture Organization] and local specifications [as required] pertaining to the requirements all nutrients including added sugars”. The company added: “Over the past 5 years, we have already reduced added sugars by up to 30%, depending on the variant. We regularly review our portfolio and continue to innovate and reformulate our products to further reduce the level of added sugars, without compromising on nutrition, quality, safety, and taste.” The report by the two organisations also showed that Cerelac wheat-based cereals, meant for consumption by six-month-old babies, contained over two grams of added sugar per serving in India, six grams in Brazil and over five grams in Ethiopia. The same product being sold in Germany and the United Kingdom did not contain any added sugar. Source: Scroll.in

Consumer rights body asks FSSAI to look into allegations about Nestlé adding sugar to baby products Read More »

Bank liable for wrong done by its employees: SC orders bank to compensate man

May 06,2024 In a recent ruling, the Supreme Court has held the District Cooperative Bank in Varanasi accountable for service lapses, affirming its vicarious liability for the actions of its employees . The apex court directed the bank to compensate a man with Rs 25,000 nearly three decades after he was wrongly denied access to his fixed deposit. A bench comprising Justices P S Narasimha and Aravind Kumar upheld the decision of the district consumer forum from 1997, which had initially granted compensation to the aggrieved individual. The National Consumer Disputes Redressal Commission’s (NCDRC) contrary ruling was overturned by the apex court. The case revolves around the non-release of fixed deposit receipts totaling Rs 1,60,000 by the District Cooperative Bank in Varanasi. The petitioner alleged that the bank had unlawfully prevented him from withdrawing his funds. The district consumer forum, upon review, ordered the bank to refund the amount along with 15% interest, and an additional Rs 25,000 in damages. The Supreme Court, in its judgment, emphasized, “It is seen from the record that the district forum was satisfied that the appellant had, in fact, handed over Rs 1,60,000 to the bank’s officials. This is evidenced from the bank’s ledger.” The court noted the establishment of an inquiry committee that recommended criminal proceedings against certain officials, which the bank had duly pursued. Additionally, it acknowledged the periodic renewal of fixed deposit receipts, thereby affirming the bank’s vicarious liability for its employees’ actions. Source: Economic TImes

Bank liable for wrong done by its employees: SC orders bank to compensate man Read More »

Airbnb, Goa host fined ₹10,000 by consumer court for accident involving infant

May 09,2024 The Consumer Disputes Redressal Commission in Chandigarh has fined the homestay marketplace Airbnb and one of its hosts ₹10,000 after a six-month-old child was accidentally injured while the property was being cleaned. The Commission President Pawanjit Singh and members Surjeet Kaur and Suresh Kumar Sardana noted an email exchange between the complainants and Airbnb, where Airbnb and the caretaker admitted to the incident and apologised. The emails from the accused clearly admit the incident on March 6, 2022, when the complainant’s six-month-old daughter, wrapped in a blanket, fell while the room was being cleaned by the caretaker, and the accused also apologised, the May 2 order stated. The commission directed both Airbnb and the property caretaker to pay ₹5,000 to the complainant as compensation, along with an additional ₹5,000 for litigation costs. The development comes after the bench heard a complaint from the child’s mother. Source: CNBCTV

Airbnb, Goa host fined ₹10,000 by consumer court for accident involving infant Read More »

Information sought under RTI Act cannot be denied citing difficulty in collating it: Delhi HC

May 09,2024 Difficulty in collating information cannot be the grounds for denying details sought under the Right to Information Act, the Delhi High Court has observed. In a judgment on May 2, Justice Subramonium Prasad said that a public authority cannot justify denying any information to an applicant under the Act by claiming that the details were not available in a single place and that would take time to collate it. “Efforts have to be made by the department to collate the information and then give it to the respondent,” the court held. Prasad observed that the objective of the Right to Information Act was to ensure transparency in the functioning of government departments and that this mandate cannot be obstructed by state governments. The judgment came on a petition filed by the Delhi government against an order of the Central Information Commission. The commission had asked the state government to provide information under the Act to applicant Prabhjot Singh Dhillon regarding actions taken by the education department against government teachers for conducting private tuitions. The Delhi government told the High Court that it could not provide such information for unaided schools as it they did not fall within its jurisdiction, reported Bar and Bench. It also said that private unaided schools do not fall under the purview of the Right to Information Act. The state said that the vigilance arm of the Department of Education had not issued any directions to maintain data on cases of misconduct by government teachers. The High Court rejected the state’s petition. Prasad remarked that information regarding actions taken against teachers of aided schools would be available with the department, though not in one place, and could be provided to Dhillon. “[The Delhi School Education Rules, 1973] stipulates that if a School intends to take a major penalty against a teacher then the approval of the Director of Education is necessary and without such an approval any action of major penalty cannot be imposed on the teacher,” the court held. “Therefore, information related to teachers of private unaided schools can be collated from the records of major punishment imposed by such schools.” Source: Scroll.in

Information sought under RTI Act cannot be denied citing difficulty in collating it: Delhi HC Read More »